Our data indicate that MCL1 and Bcl-xL cooperate at the mitochondria level to promote cancer cell survival, and MCL1 nuclear localization reconstitutes sensitivity to Bcl-xL inhibitors, phenocopying functional inhibition, or genetic ablation of MCL1 as is illustrated in our proposed model (Fig. S3B). Here, MCL1 is linked to cancer.